Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis ML Elkjaer, T Frisch, R Reynolds, T Kacprowski, M Burton, TA Kruse, ... Acta neuropathologica communications 7, 1-17, 2019 | 80 | 2019 |
Privacy-preserving artificial intelligence techniques in biomedicine R Torkzadehmahani, R Nasirigerdeh, DB Blumenthal, T Kacprowski, ... Methods of information in medicine 61 (S 01), e12-e27, 2022 | 40 | 2022 |
Federated Random Forests can improve local performance of predictive models for various healthcare applications AC Hauschild, M Lemanczyk, J Matschinske, T Frisch, O Zolotareva, ... Bioinformatics 38 (8), 2278-2286, 2022 | 32 | 2022 |
sPLINK: a hybrid federated tool as a robust alternative to meta-analysis in genome-wide association studies R Nasirigerdeh, R Torkzadehmahani, J Matschinske, T Frisch, M List, ... Genome Biology 23 (1), 32, 2022 | 24 | 2022 |
Reducing Aspergillus fumigatus virulence through targeted dysregulation of the conidiation pathway JIP Stewart, VM Fava, JD Kerkaert, AS Subramanian, FN Gravelat, ... Mbio 11 (1), 10.1128/mbio. 03202-19, 2020 | 23 | 2020 |
Carotta: revealing hidden confounder markers in metabolic breath profiles AC Hauschild, T Frisch, JI Baumbach, J Baumbach Metabolites 5 (2), 344-363, 2015 | 22 | 2015 |
sPLINK: a federated, privacy-preserving tool as a robust alternative to meta-analysis in genome-wide association studies R Nasirigerdeh, R Torkzadehmahani, J Matschinske, T Frisch, M List, ... BioRxiv, 2020.06. 05.136382, 2020 | 17 | 2020 |
Flimma: a federated and privacy-aware tool for differential gene expression analysis O Zolotareva, R Nasirigerdeh, J Matschinske, R Torkzadehmahani, ... Genome biology 22 (1), 338, 2021 | 14 | 2021 |
Multiple sclerosis atlas: A molecular map of brain lesion stages in progressive multiple sclerosis T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ... Network and systems medicine, 2020 | 14 | 2020 |
Unbiased examination of genome-wide human endogenous retrovirus transcripts in MS brain lesions ML Elkjaer, T Frisch, A Tonazzolli, R Röttger, R Reynolds, J Baumbach, ... Multiple Sclerosis Journal 27 (12), 1829-1837, 2021 | 10 | 2021 |
The featurecloud ai store for federated learning in biomedicine and beyond J Matschinske, J Späth, R Nasirigerdeh, R Torkzadehmahani, ... arXiv preprint arXiv:2105.05734, 2021 | 7 | 2021 |
The FeatureCloud platform for federated learning in biomedicine: unified approach J Matschinske, J Späth, M Bakhtiari, N Probul, MMK Majdabadi, ... Journal of Medical Internet Research 25 (1), e42621, 2023 | 6 | 2023 |
Flimma: a federated and privacy-preserving tool for differential gene expression analysis O Zolotareva, R Nasirigerdeh, J Matschinske, R Torkzadehmahani, ... arXiv preprint arXiv:2010.16403, 2020 | 3 | 2020 |
MS Atlas-A molecular map of brain lesion stages in progressive multiple sclerosis T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ... bioRxiv, 584920, 2019 | 2 | 2019 |
Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation ML Elkjaer, L Simon, T Frisch, LM Bente, T Kacprowski, M Thomassen, ... Frontiers in Immunology 13, 1043579, 2022 | 1 | 2022 |
DiMmer: Discovery of Differentially Methylated Regions in Epigenome-Wide Association Study (EWAS) Data T Frisch, J Gøttcke, R Röttger, Q Tan, J Baumbach Data Mining for Systems Biology: Methods and Protocols, 51-62, 2018 | 1 | 2018 |
Molecular signatures of different lesions types in the white matter of SPMS ML Elkjaer, T Frisch, R Reynolds, T Kacprowski, M Burton, T Kruse, ... Multiple Sclerosis Journal 25 (2 Suppl. 1), 76, 2019 | | 2019 |
The MS Atlas-A molecular map of brain lesion stages in secondary progressive MS T Frisch, ML Elkjaer, R Reynolds, TM Michel, T Kacprowski, M Burton, ... Multiple Sclerosis Journal 25 (2 Suppl. 1), 379-380, 2019 | | 2019 |
Molecular signature of brain lesion evolution and fate in progressive MS ML Elkjaer, T Frisch, M Burton, R Reynolds, T Kruse, M Thomassen, ... Multiple Sclerosis Journal 24 (Suppl. 2), 182-183, 2018 | | 2018 |
Integrin and IL-16/IL-23 biomarker clusters differentiate AQP4-IgG+ NMO spectrum disorders, relapsing-remitting MS and healthy controls HH Nielsen, S Kalluri, T Frisch, T Sejbaek, G Dale, T Petersen, T Csepany, ... | | 2017 |